Blood transfusion
throughout time
More information?
Visit www.ap.fasson.com
Asia Pacific
32/F.,SkylineTower
39WangKwongRoad
KowloonBay,Kowloon,
HongKong
T:+8522802-9618
Europe
Lammenschansweg 140
2321JXLeiden
The Netherlands
T:+3171/579-4100
Latin America
Av.Warnes2225C1427DPB-Ciudad
Autonoma de Buenos Aires
Buenos Aires, Argentina
T:+54114014-2226
North America
8080NortonParkway
Mentor, OH 44060
T:+400534-6000
1667 The first fully documented human blood transfusion
was administered by Dr. Jean-Baptiste Denys.
1818 Dr. James Blundell performs the first successful human
blood transfusion to a postpartum haemorrhage patient.
1901 - 1907 Karl Landsteiner discovers the first three human blood
groups. Ludvig Hektoen suggests that the safety of transfusion might
be improved by cross-matching blood.
1939-1940 The Rh blood group system is discovered by K. Landsteiner, A.
Wiener,P.LevineandR.E.Stetson.
© 2012 Avery Dennison Corporation. All rights reserved. Avery Dennison, Fasson and all other
Avery brands, product names and copes are trademarks of the Avery Dennison Corporation. All
other brands and product names are trademarks of their respective owners. Information displayed
on samples depicted are fictitious. Any resemblance to actual products is purely coincidental.
Fortune 500® is a registered trademark of Time, Inc.
1978 FDA requires blood bags to be labelled to clearly state
whether they are “paid” or “volunteer”.
Today approximately 25% of the worldwide population makes use of blood
transfusions each year and the percentage is expected to continue increasing at a rate
of 7-9%**. Blood banks and hospitals face a massive challenge considering that only
38% of the population is able to donate blood.*
Tremendous progress in the correct management of blood transfusions has been
made. Today blood can be used more effectively if component therapy is practiced.
One unit of donated blood can be divided into components, including red cells
1985 Immediately after the FDA licenses the first test to
detecttheantibodytoHIV,RedCrossBloodServices
regions begin testing all newly donated blood.
AD+
The future that lies ahead
Applicable to patients
of all blood types.
For Intended storage of
PLASMA products prepared from
500ml
whole blood
Do not use unless solution is clear
and container is intact
and undamaged.
Do not supply air into bag
Each 100 ml. contains:
Dextrose (monohydrate) 0.090g
Sodium Chloride 0.107g
Mannitol 0.650g
Adenine 0.020g
DONOR REFERENCE
DONOR REFERENCE
DONOR REFERENCE
DONOR REFERENCE
concentrates, fresh frozen plasma, cryoprecipitates and platelet concentrates, to meet
the needs of more than one patient.**
Avery Dennison is dedicated to improve the quality management in the entire blood
cold chain. Our label solutions are highly effective in:
• Ensuringaccuratelabelingatbedsideanddonationareas
• Providingtheabilitytotracethebloodpacketthroughouttheentirecycle
* Red Cross: www.redcrossblood.org
** World Health Organization: www.who.int/bloodsafety/en/
Did you know?*
•1pintofbloodcansaveupto3lives
•Lessthan38%ofpopulationiseligibleto
donate blood
•Plateletscriticalforcancerpatientshavea
shelf life of only 5 days
*Red Cross: www.redcrossblood.org
Demo Version, http://www.verydoc.com and http://www.verypdf.com
Disclaimer
All statements, technical information and recommendations in this brochure about Avery
Dennison products are based upon tests believed to be reliable but do not constitute
a guarantee or warranty. All Avery Dennison products are sold with the understanding
that the user has independently determined the suitability of such products for its
purposes. Although all statements and information in this publication are believed
to be accurate and reliable, they are presented gratis and for guidance only, and
risks and liability for results obtained by use of the products or application of the
recommendationsdescribedareassumedbytheuser.NOWARRANTIES,
EXPRESSORIMPLIED,INCLUDING,BUTNOTLIMITEDTO,ANY
IMPLIEDWARRANTIESOFMERCHANTABILITY,FITNESSFOR
ANYPARTICULARUSEAND/ORNON-INFRINGEMENT
AREMADEREGARDINGPRODUCTSDESCRIBED,
STATEMENTS,TECHNICALINFORMATIONAND
RECOMMENDATIONSSETFORTH.AVERYDENNISON
SPECIFICALLYDISCLAIMSANDEXCLUDESALLSUCH
WARRANTIES.INNOEVENTSHALLAVERYDENNISONBE
LIABLETOUSERORANYOTHERPARTYFORINDIRECT,
CONSEQUENTIAL,INCIDENTAL,SPECIALORPUNITIVE
DAMAGES.Norepresentative,oragentofAveryDennison
is authorized to give any guarantee or warranty or make any
representation contrary to the above. No waiver, alteration,
addition or modification of the foregoing conditions shall
be valid unless made in writing and signed by an executive
officer of Avery Dennison.
Labels that work,
in or out of the freezer
Innovative, exclusive and reliable plasma labeling solutions
Accurate
identification
The risk of an adverse outcome from an erroneous transfusion is estimated
to exceed the risk of acquiring infectious disease. About 5% to 10% of HIV
infections worldwide are the result of transfusions from contaminated blood or
blood products.*
Primary labels
In the supply chain, the bag manufacturers pre-apply the primary labels
on the blood and plasma bags before filling them with anticoagulant and
sterilization in autoclave. The primary labels (also referred to as a base label)
carry the manufacturer’s information, identification and approval icons, and
bar codes with important traceability information.
Secondary labels
The secondary labels applied during blood processing are important as they
contain information such as donor identification number, donor type, product
code and expiration information, as well as the matrix tracking bar code.
Plasma labels
AveryDennison’sPlasmaBagLabelsarespeciallydesignedforlabelingatlow
temperatures.Ourlabelswillapplyquickly,clearlyandpermanentlyonPlasma
bags right out of freezer without wiping or drying.
At Avery Dennison, we understand that self-adhesive labels play a crucial
role by ensuring correct labeling for identification and traceability at
bedsides and donation areas. Thus preventing:
• S
amplesmix-upduetosimultaneoushandlingofspecimensfrommultiple
patients
• Bloodproductmix-upduetostorageinsamecontainer
• Erroneouscross-matching
Key advantages:
Key advantages:
Key advantages:
• Suitablesterilizationinautoclave
• S
uitableforcoldsurface
applications
• L
abelswithstandtemperatures
ranging from -30 deg C to +120
• C
anbeusedforthemajorityof
the typical printing techniques in
deg C
• Goodadherenceonmoistoricy
• Goodadhesionduringthe
centrifugation and thawing in warm
*World Health Organization: www.who.int/bloodsafety/en/
water processes
• DINISO3826compliant
laboratories
• DINISO3826compliant
surfaces even at -30 deg C
• Labelsconformtounevensurfaces
Our Research & Development
• Decreaseincorrectcrossmatches
engineers designed a label construction
• A
voidwaste,reducecostsof
destroying unidentifiable products
that can meet very stringent standards
and endure extreme environmental
conditions during collection, processing
and storage:
•Withstandstemperaturesranging
Remove the labels to
Remove the labels to
Remove the labels to
from -80˚C to +120˚C
•Adheresonmoistoricysurfaces
even at -80˚C
view the advantages of
view the advantages of
view the advantages of
using Fasson blood bag
using Fasson blood bag
using Fasson blood bag
labeling material.
labeling material.
labeling material.
•Conformstofrozenwrinkledblood
plasma bags
= inserted labels
Demo Version, http://www.verydoc.com and http://www.verypdf.com